Suchergebnisse - Gwo–Tzer Ho
- Treffer 1 - 20 von 31
- Zur nächsten Seite
-
1
Multidrug resistance 1 gene (P-glycoprotein 170): an important determinant in gastrointestinal disease? von Gwo–Tzer Ho
Veröffentlicht 2003Revisão -
2
-
3
Mitochondria and Inflammatory Bowel Diseases: Toward a Stratified Therapeutic Intervention von Gwo–Tzer Ho, Arianne L. Theiss
Veröffentlicht 2021Revisão -
4
Pathogenesis of Crohn's disease von Ray Boyapati, Jack Satsangi, Gwo–Tzer Ho
Veröffentlicht 2015Revisão -
5
Ulcerative colitis: Recent advances in the understanding of disease pathogenesis von Ross J Porter, Rahul Kalla, Gwo–Tzer Ho
Veröffentlicht 2020Pré-impressão -
6
Biomarkers in Search of Precision Medicine in IBD von Ray Boyapati, Rahul Kalla, Jack Satsangi, Gwo–Tzer Ho
Veröffentlicht 2016Revisão -
7
Gut mucosal DAMPs in IBD: from mechanisms to therapeutic implications von Ray Boyapati, Adriano G. Rossi, Jack Satsangi, Gwo–Tzer Ho
Veröffentlicht 2016Revisão -
8
Advances in the understanding of mitochondrial DNA as a pathogenic factor in inflammatory diseases von Ray Boyapati, Arina Tamborska, David A. Dorward, Gwo–Tzer Ho
Veröffentlicht 2017Pré-impressão -
9
-
10
-
11
-
12
Genetics of the innate immune response in inflammatory bowel disease von Johan Van Limbergen, Richard K. Russell, Elaine R. Nimmo, Gwo–Tzer Ho, Ian Arnott, David C. Wilson, Jack Satsangi
Veröffentlicht 2006Revisão -
13
-
14
-
15
The use of adalimumab in the management of refractory Crohn’s disease von Gwo–Tzer Ho, Lesley Smith, Susan C. Aitken, H. M. Lee, Terence Ting, J. Fennell, Charlie W. Lees, K Palmér, Ian Penman, Alan G. Shand, Ian Arnott, Jack Satsangi
Veröffentlicht 2007Artigo -
16
Mitochondrial DNA Is a Pro-Inflammatory Damage-Associated Molecular Pattern Released During Active IBD von Ray Boyapati, David A. Dorward, Arina Tamborska, Rahul Kalla, Nicholas T. Ventham, Mary K. Doherty, Philip D. Whitfield, Mohini Gray, Joseph Loane, Adriano G. Rossi, Jack Satsangi, Gwo–Tzer Ho
Veröffentlicht 2018Artigo -
17
Serum Calprotectin: A Novel Diagnostic and Prognostic Marker in Inflammatory Bowel Diseases von Rahul Kalla, Nicholas A. Kennedy, Nicholas T. Ventham, Ray Boyapati, Alex Adams, Elaine R. Nimmo, Micaela Rios Visconti, Hazel E. Drummond, Gwo–Tzer Ho, Rebecca Pattenden, David C. Wilson, Jack Satsangi
Veröffentlicht 2016Artigo -
18
Purine metabolism controls innate lymphoid cell function and protects against intestinal injury von Siobhan Crittenden, Ashleigh Cheyne, Alex Adams, Thorsten Forster, Calum T. Robb, Jennifer M. Felton, Gwo–Tzer Ho, Dominik Rückerl, Adriano G. Rossi, Stephen M. Anderton, Peter Ghazal, Jack Satsangi, Sarah Howie, Chengcan Yao
Veröffentlicht 2018Artigo -
19
IBD prevalence in Lothian, Scotland, derived by capture–recapture methodology von Gareth‐Rhys Jones, Mathew Lyons, Nikolas Plevris, Philip Jenkinson, Cathy Bisset, Christopher Burgess, Shahida Din, James Fulforth, Paul Henderson, Gwo–Tzer Ho, Kathryn Kirkwood, Colin Noble, Alan G. Shand, David C. Wilson, Ian Arnott, Charlie W. Lees
Veröffentlicht 2019Artigo -
20
MDR1 deficiency impairs mitochondrial homeostasis and promotes intestinal inflammation von Gwo–Tzer Ho, Rhona Aird, B Liu, Ray Boyapati, Nicholas A. Kennedy, David A. Dorward, Colin Noble, Takahiko Shimizu, Roderick N. Carter, Etienne Chew, Nicholas M. Morton, Adriano G. Rossi, R. Balfour Sartor, John P. Iredale, Jack Satsangi
Veröffentlicht 2017Artigo
Suchwerkzeuge:
Ähnliche Schlagworte
Medicine
Disease
Biology
Immunology
Inflammatory bowel disease
Ulcerative colitis
Internal medicine
Genetics
Pathology
Gene
Inflammation
Biochemistry
Crohn's disease
Gastroenterology
Bioinformatics
Immune system
Pathogenesis
Cell biology
Colitis
Chemistry
Confidence interval
Gene expression
Biomarker
Cohort
Computational biology
DNA methylation
Genotype
Hazard ratio
Inflammatory Bowel Diseases
Infliximab